Skip to content

Insider · CIK 0001836354

Stephen Machatha

officer

Files at ALDX (Aldeyra Therapeutics, Inc.). First filing Aug 13, 2025, latest Aug 13, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $114k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

ALDX: Aldeyra Therapeutics, Inc.

ALDXOct 9, 2026 · close 0.92

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
25Weak
ALDXsell
Aldeyra Therapeutics, Inc.
$114k
22,073 shares
-9%+270% from low-25% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Aug 11, 2025ALDX
Aldeyra Therapeutics, Inc.
SOpen-market sale
Common Stock
-22,073$5.15$114k221,799Aug 13, 2025
Mar 4, 2025ALDX
Aldeyra Therapeutics, Inc.
AGrant or award
Stock Option (right to buy)derivative
+202,427$0.00$0202,427Mar 6, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Stephen Machatha: insider trades and track record | InsiderTell